Literature DB >> 20965617

Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.

Juliana Cheleski1, Josmar R Rocha, Matheus P Pinheiro, Helton José Wiggers, Albérico B F da Silva, Maria C Nonato, Carlos A Montanari.   

Abstract

The enzyme dihydroorotate dehydrogenase (DHODH) has been suggested as a promising target for the design of trypanocidal agents. We report here the discovery of novel inhibitors of Trypanosoma cruzi DHODH identified by a combination of virtual screening and ITC methods. Monitoring of the enzymatic reaction in the presence of selected ligands together with structural information obtained from X-ray crystallography analysis have allowed the identification and validation of a novel site of interaction (S2 site). This has provided important structural insights for the rational design of T. cruzi and Leishmania major DHODH inhibitors. The most potent compound (1) in the investigated series inhibits TcDHODH enzyme with Kiapp value of 19.28 μM and possesses a ligand efficiency of 0.54 kcal mol(-1) per non-H atom. The compounds described in this work are promising hits for further development.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965617     DOI: 10.1016/j.ejmech.2010.09.055

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Drug search for leishmaniasis: a virtual screening approach by grid computing.

Authors:  Rodrigo Ochoa; Stanley J Watowich; Andrés Flórez; Carol V Mesa; Sara M Robledo; Carlos Muskus
Journal:  J Comput Aided Mol Des       Date:  2016-07-20       Impact factor: 3.686

2.  Recombinant production, crystallization and crystal structure determination of dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis.

Authors:  Renata Almeida Garcia Reis; Eder Lorenzato; Valeria Cristina Silva; Maria Cristina Nonato
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-21       Impact factor: 1.056

3.  Untargeted LC-MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase.

Authors:  Lucas A Chibli; Annylory L Rosa; Maria Cristina Nonato; Fernando B Da Costa
Journal:  Metabolomics       Date:  2019-04-04       Impact factor: 4.290

4.  Menthol carbonates as potent antiparasitic agents: synthesis and in vitro studies along with computer-aided approaches.

Authors:  Camila M Clemente; Sara M Robledo; Soledad Ravetti
Journal:  BMC Complement Med Ther       Date:  2022-06-13

5.  Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.

Authors:  Kuei-Chung Shih; Chi-Ching Lee; Chi-Neu Tsai; Yu-Shan Lin; Chuan-Yi Tang
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  The Open Form Inducer Approach for Structure-Based Drug Design.

Authors:  Daniel Ken Inaoka; Maiko Iida; Toshiyuki Tabuchi; Teruki Honma; Nayoung Lee; Satoshi Hashimoto; Shigeru Matsuoka; Takefumi Kuranaga; Kazuhito Sato; Tomoo Shiba; Kimitoshi Sakamoto; Emmanuel Oluwadare Balogun; Shigeo Suzuki; Takeshi Nara; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Akiko Tanaka; Masayuki Inoue; Kiyoshi Kita; Shigeharu Harada
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 7.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

Review 8.  Role of pH in Regulating Cancer Pyrimidine Synthesis.

Authors:  Saad Saeed Alqahtani; Tomas Koltai; Muntaser E Ibrahim; Adil H H Bashir; Sari T S Alhoufie; Samrein B M Ahmed; Daria Di Molfetta; Tiago M A Carvalho; Rosa Angela Cardone; Stephan Joel Reshkin; Abdelhameed Hifny; Mohamed E Ahmed; Khalid Omer Alfarouk
Journal:  J Xenobiot       Date:  2022-07-06

9.  Babesia bovis dihydroorotate dehydrogenase (BboDHODH) is a novel molecular target of drug for bovine babesiosis.

Authors:  Ketsarin Kamyingkird; Shinuo Cao; Tatsunori Masatani; Paul Franck Adjou Moumouni; Patrick Vudriko; Ahmed Abd El Moniem Mousa; Mohamad Alaa Terkawi; Yoshifumi Nishikawa; Ikuo Igarashi; Xuenan Xuan
Journal:  J Vet Med Sci       Date:  2013-11-01       Impact factor: 1.267

10.  Crystal structures of FMN-bound and FMN-free forms of dihydroorotate dehydrogenase from Trypanosoma brucei.

Authors:  Tomomi Kubota; Osamu Tani; Tomohiko Yamaguchi; Ichiji Namatame; Hitoshi Sakashita; Koji Furukawa; Kazuhiko Yamasaki
Journal:  FEBS Open Bio       Date:  2018-03-06       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.